The company has been around for a while, manufacturing and distributing medications that are now widely used.
In early November of this year, they announced that they would be releasing a COVID-19 vaccine. With several countries purchasing millions of doses, investing in the company is a good move.
Whether you’re Australian or not, you can easily do this with online brokers. As there are so many available, we talked about 3 of the best. We also took a look at the multinational, discussing everything you need to know.
Where Can You Buy Pfizer Shares?
You can buy their shares online but you’ll have to work with trading platforms. We looked at some of the best below.
HFTrading is rather new and entered the game in 2019. The majority of their competitors have been around for much longer. However, they’ve been able to accomplish a lot in a short period, which is impressive.
Users from abroad can’t access their services, however. They are only available to Australian and New Zealand citizens. The broker is regulated by bodies from the two nations – this includes the Australian Securities and Investment Commission as well as the New Zealand Financials Market.
You can not only trade Pfizer shares but a range of other assets too:
- Global Shares
To use their services, you’ll have to make a minimum deposit of $250. Thankfully, commissions don’t have to be made. You can make payments through credit and debit card, wire transfer, Neteller, and Skrill.
If you’re a new trader, you’ll appreciate the platform as they have a thorough education center. They also have analytical tools and forecasts to help you study the market. This will allow you to invest in Pfizer when it’s the best time.
There’s an expert customer support team as well. You can reach out to them 24/5.
A mobile app is present, and being able to trade on the go is always appreciated. It comes with as many features as its web counterpart, which runs MetaTrader 4.
The broker was founded in 2010. You can access their services from many parts of the world, apart from a few. These are:
To use their services, you’ll have to make a minimum deposit of $200. Unfortunately, commissions have to be made as well. The maximum amount would be $3.5, and it depends on the payment method you’re using.
Speaking of payment methods, there are many you can choose from. You can make them through credit and debit card, wire transfer, Fasapay, Skrill, Neteller, Union Pay & Poli.
Of course, they’re highly regulated. They are governed by more bodies than HFTrading. Some of these are:
- Financial Conduct Authority
- Dubai Financial Services Authority
- Australian Securities and Investment Commission
There is an expert education center, as well. Great analytical tools and forecasts to track the market are also present, and you will have access to thorough customer support.
In terms of what you’ll be able to trade apart from global stocks (Pfizer shares) are the following:
From this list, they are best known for Forex trading. The company initially started by trading the assets.
Yes, there is a mobile app, which is extensive.
From the options we discussed, this CFD provider has been around the longest. Plus500 was founded in 2008, and is available to users in most parts of the world, except the US. Their headquarters are in Israel. However, they have subsidiaries elsewhere, such as in Singapore and the United Kingdom.
Fortunately, you won’t have to make commissions. Their minimum deposit isn’t too high, at $100.
You can make payments in several ways. This includes credit and debit cards, wire transfer, Skrill, and PayPal.
They are heavily regulated. The Australian Securities and Investment Commission as well as CySEC and the Financial Conduct Authority govern them.
The platform could be your go-to if you want good customer support. They’ve won several awards for their great services. The cherry on top is that their team can be contacted 24/7.
You can trade over 2000 assets including Pfizer shares. Some of them are:
- Global Stocks
However, their educational center is not up to par, in our opinion. It pales in comparison to its counterparts. Their mobile app makes up for this, though. There are also adequate analytical tools offered.
Plus500 Disclaimer: 76.4% of retail CFD accounts lose money.
What is Pfizer?
They are an American multinational pharmaceutical corporation. They came 57th in the 2018 Fortune 500 list. The list ranks the largest corporations in the US and takes its revenue and market value into account. Their success is attributed to their offering a diverse range of medications and vaccines.
The company has been around for a while, being founded in 1849 by Charles Pfizer and Charles F. Erhart. They started by producing Santonin, an antiparasitic. The venture was immensely successful and gave birth to the company we know today.
The multinational focused mostly on manufacturing fine-chemicals. They fully shifted to the pharmaceutical-research industry when they found an alternative to Penicillin – Terramycin.
By 1950, they were going global. Pfizer had offices in the United Kingdom, Panama, Puerto Rico, Brazil, Canada, Cuba, Belgium, and more. They also shifted their research lab operations from New York City to Connecticut, in 1980. This subsequently led them to launch the Feldene drug – an anti-inflammatory prescription medication that was their first product to reach over a billion in sales.
Some of their most successful products include:
From 2000-2010, they saw rapid acquisitions and mergers. Most notably, a merger with Warner-Lambert, Wyeth, and Pharmacia. Once they merged with Warner-Lambert, they became the second-largest pharmaceutical company in the world.
They acquired Therachon for $810 million in 2019, expanding their rare disease portfolio. They purchased Array Biopharma in June that year, expanding their expertise in the oncology field.
Of course, they’re the best-known for their work on the Covid-19 vaccine. On November 9th, 2020, they announced that it was 90% effective. By November 20th, they applied for emergency authorization and use. With the advent of the vaccine, the stocks of other companies rose – especially in the oil industry. If you are interested in investing in oil and energy, check out our guide on how to buy BP shares.
The sale of the vaccine would increase its revenue tenfold, which is something that would interest you as a trader.
|Pfizer Inc.||Company Information|
|Founders||Charles Pfizer & Charles F. Erhart|
|Current Owner(s)||Albert Bourla & Ernesto Bertarelli|
|Headquarters||Manhattan, New York City|
What Should You Consider When Buying Pfizer Shares?
Before investing in the company, keep the following points in mind if you want the best experience. We looked at a few instances where the company has been criticized. We also discussed some factors to know when choosing a broker.
Their Revenue Dropped
From 2018-2019, their revenue dropped rapidly due to the severe competition in the generic drug industry. By the end of 2019, their fourth-quarter earnings were $12.7 billion. This is a stark contrast to 2018’s Q4 when their earnings were almost 2 billion more.
Illegal Drug Marketing
The insurance company, Blue Cross Shields, filed a lawsuit against Pfizer for illegally marketing drugs such as Bextra, Geodon, and Lyrica. They reported that the multinational persuaded doctors to recommend the medications incorrectly, offering kickbacks. In 2014, the case was settled, and the corporation was made to pay $325 million.
The above wasn’t the only instance they were accused of illegally marketing medication. Wyeth, the company they acquired, was charged with illegally marketing Rapamune. This led to a federal lawsuit. The company specifically targeted African Americans to increase their sales. In 2014, Pfizer had to pay $491 million in penalties, which included criminal and civil charges.
Faulty Heart Valves
The multinational acquired Shiley in 1979, during their ordeal with the Bjork-Shiley Heart valve. Unfortunately, they were caught in the cross-fire, having to pay $200 million in compensation.
A Paralyzed Worker
A federal lawsuit was filed against the corporation. In 2003, an employee alleged that they were exposed to a genetically modified virus. Although the company did not have to pay millions, the investigation found that they violated several whistleblower laws.
The best move would be to trade on a broker with a trustworthy reputation. You can read through reviews to come to a decision.
The broker you’re interested in should be well-regulated. If it’s not, the cash flowing in and out won’t be safe.
Different brokers charge different commissions. How much are you willing to pay? You’ll also have to consider the minimum deposit you’ll be making. This will depend on the trading platform you sign up for.
Having a mobile app is a plus, however you might choose to work with a broker that doesn’t have one. However, buying and selling Pfizer shares would be easier on a mobile app, especially if you travel often and are always on the go.
Why Should You Buy Pfizer Shares?
The Covid-19 Vaccine
With news of the coronavirus vaccine, Pfizer’s revenue will certainly skyrocket in the coming months. Their goal is to send 50 million dosages by the end of this year and produce and distribute 1.3 billion by the end of 2021. The company is estimated to make around $13 billion.
What investor doesn’t love dividends? The corporation recently declared its 328th consecutive quarterly dividend. It stands at $1.52 per share annually, reporting a 4.17% yield.
GlaxoSmithKline is a major name in the pharmaceutical game. They are a British multinational, and Forbes listed them as the sixth-largest pharmaceutical company in 2019. They also made 2019’s Fortune 500 list.
You’d be pleased to know that a joint merger with Pfizer was announced in 2018. That being said, the British corporation will continue to own the majority of its shares at 68%.
Success Against Counterfeits
A major problem in the pharmaceutical industry is the distribution of counterfeit drugs. Companies lose a lot of money due to this. Thankfully, the corporation has waged a very successful war against this issue. BusinessWeek reports that Pfizer’s success is owing to its pursuit of civil lawsuits instead of criminal.
As mentioned, the corporation has seen major success due to its venture in many disciplines. They’ve been acquiring many companies, expanding their portfolio. We discussed how they purchased Array Biopharma to expand their oncology portfolio.
Is Now A Good Time to Buy Pfizer Shares?
When it comes to buying shares, now is always a good time to invest. Being risky generally pays off. It’s especially a great time to spend money on Pfizer. The multinational is releasing their vaccine across the globe, with the UK having bought 40 million doses already.
Even without the vaccine, their portfolio makes the company very tempting to invest in – you can think of sales from the vaccine as a bonus. Their venture into the oncology field has been the most rewarding. This led to its revenue growing from $1.5 billion in 2012 to $6 billion by 2018.
Of course, the company keeps dominating the industry due to its savvy marketing and business sense. With the heavy cash flow expected to come from the vaccine, a plethora of new companies will be acquired, and its popularity will keep growing.
The pharmaceutical industry is extremely lucrative, so buying stocks in Big Pharma is a smart move. The multinational is a leading name in the field, having created and distributed many well-known medications.
They grabbed the world’s attention by announcing the release of the Covid-19 vaccine. Several countries have ordered doses, and this is said to make their shares millionaire-worthy.
If you want to invest in the company, the easiest way to do so would be through an online broker. We discussed three of the best options above if you want to go ahead.